Retraction
Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Paper Information
Record ID:
41935
Author(s):
Journal:
Publication Date:
June 25, 2022
Retraction Date:
December 25, 2022
(2.9 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (3)
3
Total Citations0
Post-Retraction1
Pre-Retraction1
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
BioMed Research International
BioMed Research International
Open Access
Published: Dec 2022
1 citation
1 citation
Same day as retraction
Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity
Sang Soo Kim, Caroline Doherty, Manish Moghe et al. (7 authors)
Cancers
Open Access
Published: Oct 2022
2 citations
2 citations
68 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025